PMC full text:
Published online 2024 May 13. doi: 10.3390/jcm13102874
Table 2
Factors associated with the occurrence of major complications (septic shock, admission to intensive care unit, and death) in the study cohort.
| Patients with Major Complications N 87 | Controls N 1082 | p Value | Odds Ratio (95% Confidence Interval) | Multiv. p Value | |
|---|---|---|---|---|---|
| Age | 85 (82–88) | 85 (82–88) | 0.934 | ||
| Sex (male) | 73 (83.9%) | 836 (77.2%) | 0.148 | ||
| ED Presentation | |||||
| Triage Code | |||||
| Emergency | 9 (10.3%) | 7 (0.6%) | 18.0 [5.5–58.7] | <0.001 | |
| Urgency | 52 (59.8%) | 376 (34.7%) | <0.001 | 2.7 [1.6–4.7] | <0.001 |
| Minor Urgency | 26 (29.9%) | 700 (64.6%) | Reference | <0.001 | |
| Fever | 25 (28.7%) | 209 (19.3%) | 0.034 | 2.0 [1.1–3.5] | 0.015 |
| Abdominal Pain | 20 (23.0%) | 189 (17.5%) | 0.195 | ||
| Asthenia | 10 (11.5%) | 46 (4.2%) | 0.002 | 1.1 [0.4–2.5] | 0.883 |
| Syncope | 1 (1.1%) | 19 (1.8%) | 0.675 | ||
| Thoracic Pain | 2 (2.3%) | 15 (1.4%) | 0.493 | ||
| Confusion | 15 (17.2%) | 26 (2.4%) | <0.001 | 4.2 [1.9–3.5] | <0.001 |
| Urological history | 44 (50.6%) | 523 (48.3%) | 0.682 | ||
| Known Urological Tumor | 32 (36.8%) | 417 (38.5%) | 0.751 | ||
| Percutaneous Nephrostomy | 3 (3.4%) | 65 (6.0%) | 0.327 | ||
| IVC | 8 (9.2%) | 137 (12.7%) | 0.347 | ||
| Use of anticoagulants | 11 (12.6%) | 73 (6.7%) | 0.040 | 2.0 [0.9–4.5] | 0.077 |
| Use of Aspirin | 34 (39.1%) | 431 (39.8%) | 0.895 | ||
| Laboratory Values | |||||
| Hemoglobin | 9.8 (8.7–12.2) | 11.7 (10.2–13.1) | <0.001 | 0.8 [0.7–0.9] | <0.001 |
| WBC | 8.86 (6.9–19) | 8.2 (6.58–11.8) | 0.300 | ||
| Platelets | 254 (207–278) | 215 (164–296) | 0.332 | ||
| RDW | 14.7 (13.4–17.1) | 15 (13.9–16.7) | 0.555 | ||
| Cr | 1.2 (0.85–1.91) | 1.17 (0.88–1.66) | 0.864 | ||
| Glucose | 114 (99–162) | 120 (101–133) | 0.838 | ||
| Comorbidities | |||||
| CCI | 7 (6–9) | 6 (4–8) | <0.001 | 1.2 [1.1–1.3] | 0.002 |
| MI | 19 (21.8%) | 309 (28.5%) | 0.181 | ||
| HF | 24 (27.6%) | 268%) | 0.556 | ||
| DVT | 18 (20.7%) | 40 (3.7%) | <0.001 | ||
| TIA | 9 (10.3%) | 51 (4.7%) | 0.022 | ||
| Dementia | 13 (14.9%) | 82 (7.6%) | 0.015 | ||
| COPD | 14 (16.1%) | 89 (8.2%) | 0.013 | ||
| Hepatopathy | 0 (0.0%) | 12 (1.1%) | 0.324 | ||
| Cirrhosis | 1 (1.1%) | 9 (0.8%) | 0.756 | ||
| DM | 17 (19.5%) | 144 (13.3%) | 0.104 | ||
| CRF | 39 (44.8%) | 274 (25.3%) | <0.001 | ||
| Other Neoplasm | 32 (36.8%) | 395 (36.5%) | 0.954 | ||
| Metastasis | 7 (8.0%) | 11 (1%) | <0.001 | ||
| HIV | 0 (0%) | 2 (0.2%) | 0.688 | ||
| Outcomes | |||||
| Admission from ED | 79 (90.8%) | 360 (33.2%) | <0.001 | ||
| Open Surgery | 5 (5.7%) | 37 (3.4%) | 0.261 | ||
| Endoscopic Surgery | 15 (17.2%) | 76 (7.0%) | 0.001 | ||
| LoS | 11.3 (5.1–20.2) | 0.8 (0.2–2.2) | <0.001 | ||
Abbreviations: CCI—Charlson Comorbidity Index; COPD—Chronic Pulmonary Disease; CRF—Chronic Renal Failure; DM—Diabetes Mellitus; DVT—Deep Vein Thrombosis; ED—Emergency Department; HF—Heart Failure; IVC—Indwelling Vesical Catheter; LOS—Length of Stay; MI—Myocardial Infarction; RDW—Red Cell Distribution Width; TIA—Transient Ischemic Attack; WBC White Blood Cells.